S7 E9: Best DOAC for VTE; Muscle loss with GLP1s; CDSSs - why don't we use them?

S7 E9: Best DOAC for VTE; Muscle loss with GL...

Up next

S7 E10: "Fit Note for the Last GP" song; Best UTI Abx; Kidney Failure Risk Tool & Death; Phone Empathy & Outcomes

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. More new research to discuss for the world of general practice.First, which antibiotic is actually best for managing uncomplicated UTI - is UK guidance offering the best choice to women?Second, are you using t ...  Show more

S7 E8: Longevity of THR; GLP1a for Addiction; Analgesia for Kids

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. Three new research papers to help us along our way in general practice this month.First, how long do modern hip replacements last? How does this new data change our conversation with patients?Second, it's thou ...  Show more

Recommended Episodes

Prostate Cancer
Ninja Nerd

Send us Fan MailNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob break down the essential clinical and pathophysiologic features of Prostate Cancer, one of the most common malignancies affecting men worldwide.We begin with the epidemiology and risk factors, hig ...  Show more

#310 - The relationship between testosterone and prostate cancer, testosterone replacement therapy, and tools for predicting cancer aggressiveness and guiding therapy | Ted Schaeffer, M.D., Ph.D.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/ ...

  Show more

[Physio Explained] Exercise for knee and hip OA: key findings from recent research with Dr Anthony Teoli
Physio Network

In this episode with Dr Anthony Teoli, we explore a recent paper looking at therapeutic exercise for knee and hip OA. We discuss:

<ul><li>Treatment effects of specific inte ...  Show more

Episode 107: Colorectal Cancer Series, Pt. 9 - Metastatic Colorectal Cancer (Part 1)
The Fellow on Call: The Heme/Onc Podcast

This week, we continue our discussion of colorectal cancer, turning our attention to metastatic disease, specifically for cancers without targetable mutations. If you have not done already, we highly recommend you check out episode 104 for our GI oncology pharmacology discussi ...

  Show more